Home  »  Finance   »  Before You Sell Aehr Test Systems (NASDAQ: AEHR) S...

Before You Sell Aehr Test Systems (NASDAQ: AEHR) Shares, Here’sWhat You Need To Know.

Aehr Test Systems (NASDAQ:AEHR) shares, rose in value on Friday, 05/13/22, with the stock price up by 8.22% to the previous day’s close as strong demand from buyers drove the stock to $8.03.

Actively observing the price movement in the last trading, the stock closed the session at $7.42, falling within a range of $7.60 and $8.14. The value of beta (5-year monthly) was 1.40 whereas the PE ratio was 52.14 over 12-month period. Referring to stock’s 52-week performance, its high was $27.09, and the low was $1.94. On the whole, AEHR has fluctuated by -14.67% over the past month.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.

Sponsored

With the market capitalization of Aehr Test Systems currently standing at about $230.14 million, investors are eagerly awaiting this quarter’s results, scheduled for Apr 06, 2022 – Apr 11, 2022. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be $0.04, which is expected to increase to $0.15 for fiscal year $0.42 and then to about $0.69 by fiscal year 2023. Data indicates that the EPS growth is expected to be 400.00% in 2023, while the next year’s EPS growth is forecast to be 64.30%.

Analysts have estimated the company’s revenue for the quarter at $9.03 million, with a low estimate of $9.03 million and a high estimate of $9.03 million. Wall Street analysts also predicted that in 2023, the company’s y-o-y revenues would reach $50.46 million, representing an increase of 204.00% from the revenues reported in the last year’s results.

Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that AEHR’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium term indicators have put the stock in the category of 100% Sell while long term indicators on average have been pointing out that it is a 100% Sell.

The stock’s technical analysis shows that the PEG ratio is about 2.61, with the price of AEHR currently trading nearly -0.22% and -15.04% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 46.52, while the 7-day volatility ratio is showing 9.20% which for the 30-day chart, stands at 8.20%. Furthermore, Aehr Test Systems (AEHR)’s beta value is 1.49, and its average true range (ATR) is 0.68.

A comparison of Aehr Test Systems (AEHR) with its peers suggests the former has fared considerably weaker in the market. AEHR showed an intraday change of 8.22% in last session, and over the past year, it grew by 282.38%%. In comparison, FormFactor Inc. (FORM) has moved higher at 3.39% on the day and was up 16.51% over the past 12 months. On the other hand, the price of Teradyne Inc. (TER) has risen 5.39% on the day. The stock, however, is off -12.26% from where it was a year ago. Additionally, there is a gain of 4.55% for inTEST Corporation (INTT) in last trading while the stock has seen an overall depriciation of -42.96%% over the past year. The PE ratio stands at 52.14 for Aehr Test Systems, compared to 33.12 for FormFactor Inc., and 20.07 for Teradyne Inc. Other than that, the overall performance of the S&P 500 during the last trading session shows that it gained 2.39%. Meanwhile, the Dow Jones Industrial Improved by 1.47%.

Data on historical trading for Aehr Test Systems (NASDAQ:AEHR) indicates that the trading volumes over the past 3 months, they’ve averaged 634.91K. According to company’s latest data on outstanding shares, there are 26.87 million shares outstanding.

Nearly 4.80% of Aehr Test Systems’s shares belong to company insiders and institutional investors own 41.70% of the company’s shares. The stock has fallen by -66.79% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the AEHR stock heading into the next quarter.

Leave a Comment

Your email address will not be published.

Related Videos

Related Posts

NAVB

New Outlook On Pfizer Inc.

Pfizer Inc. (NYSE:PFE) price on Thursday, May 26, rose 1.69% above its previous day’s close as an upside momentum from buyers pushed the stock’s value

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam